M&A Deal Summary |
|
|---|---|
| Date | 2010-09-07 |
| Target | GlaxoSmithKline - Medical Research Croatia |
| Sector | Life Science |
| Buyer(s) | Galapagos |
| Sellers(s) | GSK |
| Deal Type | Divestiture |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 1999 |
| Sector | Life Science |
| Employees | 683 |
| Revenue | 276M EUR (2024) |
Galapagos is a clinical stage biotech company focused on developing novel mode of action medicines. Galapagos was incorporated in 1999 and is based in Mechelen, Belgium.
| DEAL STATS | # |
|---|---|
| Overall | 6 of 9 |
| Sector: Life Science M&A | 6 of 8 |
| Type: Divestiture M&A Deals | 4 of 5 |
| Country: Croatia M&A | 2 of 2 |
| Year: 2010 M&A | 2 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2010-09-01 |
Fidelta
Zagreb, Croatia Fidelta Ltd. is a drug discovery service company with core scientific competencies in inflammation, fibrosis, and anti-infectives. The scope of services provided by Fidelta is complementary to Selvita’s offerings and will enable Selvita to build a competitive advantage in business areas such as DMPK, in vivo pharmacology, and toxicology, as well as increase its scale of operations within medicinal chemistry and in vitro pharmacology. Fidelta is based in Zagreb, Croatia. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2011-06-01 |
Compound Focus
385 Oyster Point Boulevard Suite 1, California, United States Compound Focus, Inc. is a small molecule compound management services. |
Buy | €13M |
| Category | Company |
|---|---|
| Founded | 1715 |
| Sector | Life Science |
| Employees | 68,629 |
| Revenue | 31.4B GBP (2024) |
GSK is a multinational pharmaceutical, biologics, vaccines and consumer healthcare company. GSK was founded in 1715 and is based in Brentford, United Kingdom.
| DEAL STATS | # |
|---|---|
| Overall | 6 of 24 |
| Sector: Life Science M&A | 5 of 17 |
| Type: Divestiture M&A Deals | 6 of 23 |
| Country: Croatia M&A | 2 of 2 |
| Year: 2010 M&A | 3 of 3 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2010-09-01 |
Fidelta
Zagreb, Croatia Fidelta Ltd. is a drug discovery service company with core scientific competencies in inflammation, fibrosis, and anti-infectives. The scope of services provided by Fidelta is complementary to Selvita’s offerings and will enable Selvita to build a competitive advantage in business areas such as DMPK, in vivo pharmacology, and toxicology, as well as increase its scale of operations within medicinal chemistry and in vitro pharmacology. Fidelta is based in Zagreb, Croatia. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2010-12-06 |
Nanjing MeiRui Pharma Co.
Shanghai, China Nanjing MeiRui Pharma Co. Ltd. is a Chinese pharmaceutical business with a strong portfolio of urology and allergy products, including Prostat for benign prostatic hyperplasia and Sheniting for overactive bladder syndrome. |
Buy | $70M |
